This study aimed to determine the prevalence of rheumatoid arthritis in the United States (US) adult insured population from 2004 to 2014. This was an observational, retrospective, cross-sectional study based on US administrative health insurance claims databases (Truven Health MarketScan® Research database and IMS PharMetrics Plus database). Trends in RA prevalence focusing on the 10-year period covering January 1, 2004–December 31, 2014 were analyzed using a validated algorithm for the identification of RA. Prevalence rates in the databases were determined and age- and gender-adjusted rates were projected to the US population in 2014. Analysis of data from the two databases indicated that the RA prevalence rate in commercially insured adult US population ranged from 0.41 to 0.54% from 2004 to 2014. The prevalence varied substantially by gender and age in each year and increased gradually across the years for most subgroups. In 2014, out of 31,316,902 adult patients with continuous enrollment in the Truven Health MarketScan® Research database, 157,634 (0.50%) patients met our criteria for RA. Similarly, out of 35,083,356 adult patients in the IMS PharMetrics Plus database, 139,300 (0.50%) patients met our criteria for RA. In 2014, the overall age-adjusted prevalence of RA ranged from 0.53 to 0.55% (0.29–0.31% for males and 0.73–0.78% for females). The prevalence of RA in the US appeared to increase during the period from 2004 to 2014, affecting a conservative estimate of 1.28–1.36 million adults in 2014.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Alamanos Y, Drosos AA (2005) Epidemiology of adult rheumatoid arthritis. Autoimmun Rev 4:130–136
Riise T, Jacobsen BK, Gran JT (2001) Incidence and prevalence of rheumatoid arthritis in the county of Troms, northern Norway. J Rheumatol 27:1386–1389
Simonsson M, Bergman S, Jacobsson LT et al (1999) The prevalence of rheumatoid arthritis in Sweden. Scand J Rheumatol 28:340–343
Symmons D, Turner G, Webb R et al (2002) The prevalence of rheumatoid arthritis in the UK: new estimates for a new century. Rheumatology (Oxford) 41:793–800
Power D, Codd M, Ivers L et al (1999) Prevalence of rheumatoid arthritis in Dublin, Ireland: a population based survey. Ir J Med Sci 168:197–200
Aho K, Kaipiainen-Seppänen O, Heliövaara M et al (1998) Epidemiology of rheumatoid arthritis in Finland. Semin Arthritis Rheum 27:325–334
Gabriel SE, Crowson CS, O’Fallon WM (1999) The epidemiology of rheumatoid arthritis in Rochester, Minnesota, 1955–1985. Arthritis Rheum 42:415–420
Simons WR, Rosenblatt LC, Trivedi DN (2012) The economic consequences of rheumatoid arthritis: analysis of Medical Expenditure Panel Survey 2004, 2005, and 2006 Data. J Occup Environ Med 54:48–55
Helmick CG, Felson DT, Lawrence RC et al (2008) Estimates of the prevalence of arthritis and other rheumatic condition in the US. Arthritis Rheum 58:15–25
Sacks JJ, Luo YH, Helmick CG (2010) Prevalence of specific types of arthritis and other rheumatic conditions in the ambulatory health care system in the US, 2001–2005. Arthritis Care Res 62:460–464
Widdifield J, Labrecque J, Lix L et al (2013) Systematic review and critical appraisal of validation studies to identify rheumatic diseases in health administrative databases. Arthritis Care Res 65:1490–1503
Kim SY, Servi A, Polinski JM et al (2011) Validation of rheumatoid arthritis diagnoses in health care utilization data. Arthritis Res Ther 13:R32
Hanly JG, Thompson K, Skedgel C (2015) The use of administrative health care databases to identify patients with rheumatoid arthritis. Rheumatol Res Rev 7:69–75
MacLean C, Louie R, Leake B et al (2000) Quality of care for patients with rheumatoid arthritis. JAMA 284:984–992
Kim SY, Servi A, Polinski JM et al (2011) Validation of rheumatoid arthritis diagnoses in health care utilization data. Arthritis Res Ther 13(1):R32
Lacaille D, Anis AH, Guh DP et al (2005) Gaps in care for rheumatoid arthritis: a population study. Arthritis Rheum 53(2):241–248
Shipton D, Glazier RH, Guan J et al (2004) Effects of specialty services on disease-modifying antirhematic drug use in the treatment of rheumatoid arthritis in an insured elderly population. Med Care 42(9):907–913
Widdifield J, Bombardier C, Bernatsky S et al (2014) An administrative data validation study of the accuracy of algorithms for identifying rheumatoid arthritis: the influence of the reference standard on algorithm performance. BMC Musculoskelet Disord 15:216
Myasoedova E, Crowson CS, Kremers HM et al (2010) Is the incidence of rheumatoid arthritis rising? Results from Olmsted County, Minnesota: 1955–2007. Arthritis Rheum 62:1576–1582
Sokka T, Kautianinen H, Pincus T et al (2010) Work disability remains a major problem in rheumatoid arthritis in the 2000s: data from 32 countries in the QUEST-RA study. Arthritis Res Ther 12:R42
Allaire S, Wolfe F, Niu J et al (2008) Contemporary prevalence and incidence of work disability associated with rheumatoid arthritis in the US. Arthritis Rheum 59:474–480
Conflict of interest
The authors declare that there are no potential conflicts of interest with respect to the research, authorship and/or publication of this article.
The study has been performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and later amendments.
Human or animal participants
This study was a retrospective analysis of administrative claims data and does not contain any human participants or animals.
The permission from a research ethics committee was not required and formal informed consent was not obtained.
Electronic supplementary material
Below is the link to the electronic supplementary material.
About this article
Cite this article
Hunter, T.M., Boytsov, N.N., Zhang, X. et al. Prevalence of rheumatoid arthritis in the United States adult population in healthcare claims databases, 2004–2014. Rheumatol Int 37, 1551–1557 (2017). https://doi.org/10.1007/s00296-017-3726-1
- Rheumatoid arthritis
- Claims databases